FindTrial
Sign In

COMPARISON OF TWO DRUG REGIMEN FOR TREATMENT OF EARLY PREGNANCY FAILURE

COMPARISON OF MIFEPRISTONE FOLLOWED BY MISOPROSTOL WITH MISOPROSTOL ALONE FOR TREATMENT OF EARLY PREGNANCY FAILURE

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2013/03/003492
Enrollment
92
Registered
2013-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with early pregnancy failure

Interventions

Intervention1: Mifepristone followed by Misoprostol versus Placebo followed by Misoprostol: Comparison of mifepristone followed by misoprostol with misoprostol alone for treatment of early pregnancy f

Sponsors

University College of Medical Sciences and Guru Teg Bahadur Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women with early pregnancy failure less than or equal to 12 weeks.

Exclusion criteria

Exclusion criteria: 1. Incomplete abortion as defined as open cervix and large amount of cramping / bleeding. 2. Hemodynamic instability / heavy vaginal bleeding. 3. Hemoglobin less than or equal to 8 g%. 4. Inability to follow-up (i.e. lack of transportation / access to telephone). 5. Bleeding disorder / taking anticoagulants. 6. Obvious infection. 7. Allergy to mifepristone / misoprostol.

Design outcomes

Secondary

MeasureTime frame
Emergency admission rate, blood transfusion rate, side effects, number of women who would choose medical management in futureTimepoint: 14 days post intervention—

Primary

MeasureTime frame
Need for surgical evacuationTimepoint: 14 days post intervention—

Countries

India

Contacts

Public ContactPriya Sinha

UCMS and GTB Hospital

amita_suneja@yahoo.co.in9868399728

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026